TY - JOUR
T1 - Prevalence and safety of robotic surgery for gastrointestinal malignant tumors in Japan
AU - Nishigori, Tatsuto
AU - Ichihara, Nao
AU - Obama, Kazutaka
AU - Uyama, Ichiro
AU - Miyata, Hiroaki
AU - Inomata, Masafumi
AU - Kakeji, Yoshihiro
AU - Kitagawa, Yuko
AU - Sakai, Yoshiharu
N1 - Publisher Copyright:
© 2022 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterology.
PY - 2022/11
Y1 - 2022/11
N2 - Aim: The National Health Insurance system has reimbursed robotic gastrointestinal surgery since April 2018 in Japan. Additionally, strict facility and surgeon standards were established by the government and the academic society. This study aimed to evaluate the prevalence and safety of robotic surgery using a Japanese nationwide web-based database. Methods: Patients who underwent the following robotic surgeries for malignant tumors in 2018 were included: esophagectomy (RE), total gastrectomy (RTG), distal gastrectomy (RDG), proximal gastrectomy (RPG), low anterior resection (RLAR), and rectal resections other than RLAR (RRR). The number of cases and surgical mortality rates each month were calculated to evaluate the prevalence and safety of robotic procedures. Results: A total of 3281 patients underwent robotic gastrointestinal surgery. The monthly number of robotic surgeries nearly doubled in April 2018 when they were initially reimbursed by the National Health Insurance system. Operative mortality rates were 0.9%, 0.4%, 0.2%, and 2.8% for RE (n = 330), RTG (n = 239), RDG (n = 1167), and RPG (n = 109), respectively. No mortality was observed in RLAR (n = 1062) or RRR (n = 374). Conclusion: Robotic surgery for gastrointestinal malignant tumors was safely introduced into daily clinical practice along with rigorous surgeon and facility standards in Japan.
AB - Aim: The National Health Insurance system has reimbursed robotic gastrointestinal surgery since April 2018 in Japan. Additionally, strict facility and surgeon standards were established by the government and the academic society. This study aimed to evaluate the prevalence and safety of robotic surgery using a Japanese nationwide web-based database. Methods: Patients who underwent the following robotic surgeries for malignant tumors in 2018 were included: esophagectomy (RE), total gastrectomy (RTG), distal gastrectomy (RDG), proximal gastrectomy (RPG), low anterior resection (RLAR), and rectal resections other than RLAR (RRR). The number of cases and surgical mortality rates each month were calculated to evaluate the prevalence and safety of robotic procedures. Results: A total of 3281 patients underwent robotic gastrointestinal surgery. The monthly number of robotic surgeries nearly doubled in April 2018 when they were initially reimbursed by the National Health Insurance system. Operative mortality rates were 0.9%, 0.4%, 0.2%, and 2.8% for RE (n = 330), RTG (n = 239), RDG (n = 1167), and RPG (n = 109), respectively. No mortality was observed in RLAR (n = 1062) or RRR (n = 374). Conclusion: Robotic surgery for gastrointestinal malignant tumors was safely introduced into daily clinical practice along with rigorous surgeon and facility standards in Japan.
KW - gastrointestinal neoplasms
KW - mortality
KW - registries
KW - robotic surgery
KW - social control
UR - http://www.scopus.com/inward/record.url?scp=85130234318&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85130234318&partnerID=8YFLogxK
U2 - 10.1002/ags3.12579
DO - 10.1002/ags3.12579
M3 - Article
AN - SCOPUS:85130234318
SN - 2475-0328
VL - 6
SP - 746
EP - 752
JO - Annals of Gastroenterological Surgery
JF - Annals of Gastroenterological Surgery
IS - 6
ER -